News >> Magazine >> Pharmaceutical Executive

FDA Funds Initiative to Address Disparities in Real World Data


How purpose-built tech can help pharmaceutical and life science companies streamline healthcare provider interactions


Female Board Members Are Good for Business


Understanding the true cost of transparency reporting


Q&A With Jim Lang, CEO at Eversana


How to Accelerate Adoption and Lower TCO With a Configurable RTSM System


Amgen to buy Horizon Therapeutics in $26.4B deal


TogoRun Named to Inc.'s 2022 Best in Business List in Marketing


MAPay to Create First 100 Million NFTs for Digital Health Records on the Algorand Blockchain


Brand Institute Outlines the Benefits of Early Clinical Trial Branding


Inizio acquires Evolution Road


A Changing Horizon for Digital Health Technologies


Rising Demand Drives Drug Shortages


Research Shows Improvement In Research-Based Pharma Industry Reputation


Biopharma’s Untapped Value: The Quest to Reverse First-Launch Failure Trends


2023 Pipeline Report: Testing the Limits


Business and Passion


Back in Person, Sparks Could Fly at Upcoming J.P. Morgan Conference


Aligning Trust and Transparency in Brand Messaging


Pandemic and Politics Shaped Pharma and FDA in 2022


Medical Affairs Uptick


Pharmaceutical Executive, December 2022 Issue (PDF)


The Gap In Mental Health Treatments: Schizophrenia


Aktana Releases Study On Physician Engagement


Havas Health & You Expands Content Expertise Through Partnership with Evermed


Fingerpaint Group Launches Campaign to Help Men See Therapy as a Strength


TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma


CVS Testing Remote Prescriptions


Mastering Patient Centricity’s Moving Parts: Innovators Share Real-World Examples


Doing More With Less: How Automation is Reshaping Drug Safety


Q&A With Chris Schneider, Vertical Marketing Lead, Pharma Health & Wellness for Roku


Advanced methodologies for signal detection in emergency-use cases (COVID-19)


Digital Medicine and Pharma: The Partnerships Bringing Together Molecule and Software


Pfizer's Bourla Rebuked by UK's Prescription Medicines Code of Practice Authority (PMCPA) for Misleading Comments on Kids' Vaccines


Q&A with Christopher Price, Boehringer Ingelheim's Go-to-Market Content Lead


Dr. Cheryl Pegus, former Walmart EVP of Health & Wellness, Joins Morgan Health


Tuning Into CTV - Real Time Data For Marketers


How Clinical Trials Can Thrive in the Digital Era


    
Most Read

2023-02-09 09:38:54